Biotechnology Stocks I Performance Guide: TG Therapeutics, Inc. (TGTX)
TGTX has no dividends
Table and Chart of TGTX Performance
See what a $1,000 investment in TGTX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| TGTX Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $3.90 |
| End Date | Dec-01-2023 |
| End Price | $13.83 |
| # Prices | 121 |
| Min Date | Dec-31-2013 |
| Min Price | $3.90 |
| Max Date | Dec-31-2020 |
| Max Price | $52.02 |
| Total Return | 254.62% |
| Annualized Return | 13.38% |
| Current Value of $1,000 Purchase | $3,546 |
| Number Returns | 7,260 |
| Average Return | 75.62% |
| Number Profitable Returns | 4,288 |
| Percent Profitable Returns | 59.06% |
| Number Unprofitable Returns | 2,972 |
| Percent Unprofitable Returns | 40.94% |
| Profitable to Unprofitable Returns Ratio | 1.44 |
| TGTX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,094,000,000 | Price to Sales | 11.03 |
| Earnings per Share | $-0.1900 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 12.72 |
| PRICE DATA | |
| 52 Week High | $35.67 |
| 52 Week Low | $6.46 |
| Analyst Target Price | $26.83 |
| 50-Day Moving Average | $9.34 |
| 200-Day Moving Average | $16.9 |
| FINANCIAL DATA | |
| Revenue per Share | $1.351 |
| Revenue | $189,771,000 |
| Profit Margin | -13.7% |
| Return on Equity | -0.195% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
TGTX Compare Returns with S&P 500
TGTX Trendline Chart